Division of Pediatric Endocrinology, Chulalongkorn University, Bangkok, Thailand.
Horm Res Paediatr. 2010;73(5):349-54. doi: 10.1159/000308167. Epub 2010 Apr 14.
AVPR2 mutations cause most cases of nephrogenic diabetes insipidus (NDI); 211 AVPR2 mutations have been described, but only 7 are described causing partial NDI.
Two unrelated Thai boys had polyuria and polydipsia in infancy but had normal electrolytes and serum osmolality at 2 years of age. Patient 1 could not concentrate his urine in response to water deprivation or 1-desamino-8-D-arginine vasopressin (DDAVP); patient 2 could concentrate to approximately 600 mosm/l. The patients' AVPR2 genes were sequenced and the identified mutations were re-created in AVPR2 cDNA expression vectors. AVPR2 activities were measured by stimulating transfected HEK293T cells with arginine vasopressin (AVP) or DDAVP, and assessing the resulting cAMP production by the activation of a luciferase reporter.
Patient 1 carried the previously described missense mutation R181C; patient 2 carried the novel missense mutation M311V. When transiently transfected into HEK293T cells, 6.8 x 10(-12) M AVP induced the half-maximal response (EC50) of the wild-type, whereas the EC50 value for R181C was 5.9 x 10(-9) M and for M311V was 2.6 x 10(-10)M. Responses to DDAVP were qualitatively similar but required 10-fold higher concentrations.
The novel AVPR2 mutation M311V retains partial activity and results in a milder form of NDI.
AVPR2 突变导致大多数肾性尿崩症(NDI)病例;已经描述了 211 种 AVPR2 突变,但只有 7 种被描述为导致部分 NDI。
两名无关的泰国男孩在婴儿期有多尿和多饮,但在 2 岁时电解质和血清渗透压正常。患者 1 不能在禁水或 1-脱氨-8-D-精氨酸加压素(DDAVP)的刺激下浓缩尿液;患者 2 可以浓缩至约 600mosm/l。对患者的 AVPR2 基因进行测序,并在 AVPR2 cDNA 表达载体中重新构建鉴定出的突变。通过用血管加压素(AVP)或 DDAVP 刺激转染的 HEK293T 细胞来测量 AVPR2 活性,并通过激活荧光素酶报告来评估由此产生的 cAMP 产生来评估 AVPR2 活性。
患者 1 携带先前描述的错义突变 R181C;患者 2 携带新的错义突变 M311V。当瞬时转染到 HEK293T 细胞中时,6.8 x 10(-12) M AVP 诱导野生型的半最大反应(EC50),而 R181C 的 EC50 值为 5.9 x 10(-9) M,M311V 的 EC50 值为 2.6 x 10(-10) M。对 DDAVP 的反应在性质上相似,但需要 10 倍更高的浓度。
新的 AVPR2 突变 M311V 保留部分活性,并导致更温和的 NDI 形式。